Options and cost effectiveness of multicomponent blood collection

Multicomponent blood collection (MCBC) has the potential to collect more than one blood component in one session resulting in high-quality blood products. For some protocols, an appropriate donor selection is required. Collection efficiency data of red cell apheresis show values >82%. Quality control data (hemolysis and biochemical parameter) prove that MCBC products fit European guidelines. MCBC provides standardized blood products tailored to needs of patients. MCBC is already the cost-effective alternative for filtered and double unit blood components. MCBC will lead to saving of staff, space, and equipment. It can improve logistics of blood collection and banking. MCBC increases blood supply at lower transfusion risk for national blood self-sufficiency with limited human resources and shrinking donor population.